Multicellular 3D biological models, the so-called “-oids”, are the pivot key for the new generation of high-content screening (HCS) of drug analysis, cancer research, and regenerative medicine. However, the standardisation of 3D cell culture generation, handling, imaging, and data analysis remains a challenge and lacks convincing applications. In this work, we propose HCS-3D X , a next-generation system revolutionising HCS research in 3D imaging and evaluation. HCS-3D X is based on three main components: an automated Artificial Intelligence (AI)-driven micromanipulator for oid selection, an engineered HCS foil multiwell plate for optimised imaging, and an image-based software for single-cell data analysis. The developed system was validated through different experiments with 3D tumour models, including tumour-stroma co-cultures. The results prove that the resolution achievable with HCS-3D X enables us to overcome the limitations of current systems and reliably perform 3D high-content screening (HCS) at the single-cell level.
No takes yet. Share an insight, caveat, or question.
Diósdi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: